FYI: The "lifetime use" framing is drug company spin. (And the science is starting to push back.)
Why "you have to take this forever" is positioning, not consensus. UK NICE has a 2-year cap. Real-world data shows fewer than 1 in 4 patients stay on a GLP-1 after 1 year. The cost-effectiveness studies say current prices fail at lifetime use. The federal government just delayed Medicare expansion. The evidence is shifting. The marketing hasn't.
